Crispr Therapeutics AG (CRSP) Receives Average Rating of “Hold” from Brokerages
20 Mar 2019
Baseball Daily News
Shares of Crispr Therapeutics AG (NASDAQ:CRSP) have been given a consensus rating of “Hold” by the seventeen analysts that are covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, th